Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Vascular Disorders
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Vascular Disorders
    ONTARGET Substudy Shows No Benefits for Combination Therapy for Prevention of Vascular Events in High-Risk Patients: Presented at ASH(HYP) - (DGDispatch)
    TopAbstracts in Vascular Disorders 05/15/2008 - (DGNews)
    Higher Levels of Cholesterol Bode Badly for Older Survivors of Endarterectomy: Presented at ESC - (DGDispatch)
    Vascular Calcifications on Mammography Foretell Coronary Disease and Diabetes Risks: Presented as ASBS - (DGDispatch)
    TopAbstracts in Vascular Disorders 05/01/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Vascular Disorders
    • Tackling a Silent Threat: Implications and Management of Peripheral Artery Disease
    • Peripheral Artery Disease: A Highly Prevalent Disease Remains Underdiagnosed and Undertreated
    • Diagnosing Peripheral Artery Disease: The Importance of Using the Ankle-Brachial Index
    • Progress and Promise in RAAS Blockade
      Postprandial Inflammation: The Fire Within

      Webcasts/CME archive

       Recent cases - Vascular Disorders
        Spinal Dural Arteriovenous Fistula: A Treatable Cause of Myelopathy
        Massive Hematuria Due to Congenital Renal Arteriovenous Malformation Mimicking a Renal Pelvis Tumor: A Case Report
        Bilateral Giant Femoropopliteal Artery Aneurysms: A Case Report
        A Case of Hyperreninemic Hypertension with Bilateral Positive Captopril Renography but without Renovascular Stenosis
        Percutaneous Management of a Traumatic Arteriovenous Fistula

        Cases archive
          




        my personal edition > vascular disorders > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Nitric Oxide Donor Curbs Asymptomatic Embolisation After Carotid Angioplasty

        A DGReview of :"S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty."
        Circulation

        12/24/2002
        By Anne MacLennan


        The nitric oxide donor S-nitrosoglutathione (GSNO) rapidly curbs frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.

        This is the finding of researchers in England following an evaluation of the effectiveness of GSNO in reducing embolisation after carotid angioplasty.

        Embolic stroke is the major complication of carotid angioplasty and may occur after balloon inflation and deflation or in the early postintervention period.

        In early post-angioplasty embolisation and stroke, a key role appears to be played by platelet adhesion and aggregation to the angioplasty site, with subsequent embolisation.

        During this period, despite aspirin and heparin treatment, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound.

        Dr Z Kaposzta and colleagues from the Clinical Neuroscience, St George's Hospital Medical School, London, examined the effect of GSNO because this nitric oxide donor appears to have relative platelet specificity.

        Study participants were 16 patients undergoing carotid angioplasty and stenting for symptomatic 70 percent or more internal carotid artery stenosis.

        They were randomly assigned in a double-blind manner to either GSNO or to placebo given after surgery for 90 minutes. All patients were also pre-treated with aspirin and given heparin for 24 after the procedure.

        For one hour before treatment and at zero to three, six and 24 hours after treatment, researchers did transcranial Doppler recordings from the ipsilateral middle cerebral artery.

        The GSNO treatment resulted in a rapid reduction in frequency of embolic signals of 95 percent at zero to three hours and 100 percent at six (P=0.007 and P=0.01 versus placebo, respectively).

        Although two patients in the placebo group experienced ipsilateral stroke after the angioplasty, no cerebrovascular events occurred in the patients on GSNO treatment.
        Circulation 2002;106(24):3057-62. "S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send